NEW YORK – Illumina and Sequoia Capital China announced on Wednesday the selection of the first two startups to join their Chinese genomics incubator for a six-month funding period. Mobidrop Biotechnology is a device company developing single-cell sequencing microfluidic technologies for applications in molecular diagnostics. Sequanta Technologies is a multiomics company building platforms for research and clinical applications. The Shanghai-based firm signed a strategic partnership with Mission Bio to offer single-cell sequencing services in China in July. Each firm will receive access to investment, business guidance, and use of Illumina sequencing systems and reagents. "The launch of this incubator marks…